| Cat. No. |
Product Name |
Information |
| PC-28722 |
YNW-1
EGFR inhibitor
|
YNW-1 is a bident, covalent EGFR inhibitor with IC50 of 15.82 nM, 18.97 nM and 62.45 nM for EGFR L858R Ba/F3, EGFR L858R/C775S Ba/F3, and EGFR L858R/C797S Ba/F3 cells respectvely, covalently targets both cysteines 775 and 797 simultaneously. |
| PC-28718 |
ZNL-0056
EGFR inhibitor
|
ZNL-0056 is a potent, bident, ATP-competitive inhibitor targets both the Cys797 and Cys775 in the ATP binding site of EGFR, demonstrates antiproliferative activity and downstream signaling in mutant EGFR Ba/F3 cells. |
| PC-28439 |
MKH066
HER2 inhibitor
|
MKH066 is a potent, selective HER2 tyrosine kinase inhibitor with IC50 of 2.5 nM against both EGFR and HER2. |
| PC-27975 |
BJ-2412
RYK inhibitor
|
BJ-2412 is a small molecule inhibitor of receptor-like tyrosine kinase RYK, inhibits RYK phosphorylation by disrupting its interaction with EGFR, shows anticancer activity against PDAC. |
| PC-27403 |
FHND9041
EGFR T790M inhibitor
|
Adonertinib (FHND9041) is a third-generation, irreversible EGFR T790M mutation-selective inhibitor, selectively inhibitsphosphorylation of EGFR mutant kinase and the activation of its downstream key signaling molecules, Akt and Erk, thereby inhibiting the proliferation of tumor cells with EGFR T790M resistance or sensitive mutations and inducing apoptosis of tumor cells. |
| PC-27288 |
ZW-49
EGFR inhibitor
|
ZW-49 is a potent, selective and covalent inhibitor of all subgroups of EGFR mutations with IC50 of 1.5 nM (EGFR L858R/T790M), potently inhibits all subgroups of EGFR mutations with selectivity over wild-type EGFR and other target families. |
| PC-26757 |
IAM1363
HER2 inhibitor
|
IAM1363 (IAM-1363, IAM-H1, ENT-H1) is a potent, irreversible and selective Type II inhibitor of HER2, prevents phosphorylation and activation of wild-type HER2 and variants with activating mutations in the tyrosine kinase domain. |
| PC-26663 |
SH-1092
EGFR inhibitor
|
SH-1092 is a potent third generation EGFR inhibitor with IC50 of 0.96 nM and 6.1 nM for EGFR(T790M/L858R) and EGFR(WT) respectively. |
| PC-25509 |
Tarloxotinib
pan-HER inhibitor
|
Tarloxotinib (TH-4000) is a hypoxia-activated pan-HER inhibitor, generates the active form TH-4000Effector (TH-4000E) under hypoxic condition, TH-4000E selectively inhibits EGFR, HER2 and HER4 with IC50 of <1 nM. |
| PC-25435 |
AZ14289671
EGFR inhibitor
|
AZ14289671 is a potent, highly selective and blood-brain barrier penetrant irreversible inhibitor of EGFR exon 20 insertion (EGFRExon20Ins) mutations, inhibits EGFR phosphorylation across EGFRExon20Ins with IC50 of 17-41 nM, spares wild-type EGFR. |
| PC-25021 |
Sevabertinib
HER2 inhibitor
|
Sevabertinib (BAY 2927088) is a potent, selective, reversible inhibitor of mutant epidermal growth factor receptors 2 (HER2), including HER2 exon 20 insertions and HER2 point mutations. |
| PC-24971 |
Pebezertinib
EGFR inhibitor
|
Pebezertinib (BLU-451, LNG-451) is a potent, CNS-penetrant, wild-type EGFR sparing inhibitor of EGFR exon 20 insertion mutations, as well as atypical (G719C, G719S, L861Q) and common EGFR mutants. |